Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Report of the APhA and APhA-ASP Houses of Delegates.

Bzowyckyj A, Oestreich J, Kirk LM.

J Am Pharm Assoc (2003). 2015 Jul-Aug;55(4):340, 342-4, 346-7. doi: 10.1331/JAPhA.2015.15521. No abstract available.

PMID:
26161477
2.

Impact of a high-fat meal on assessment of clopidogrel-induced platelet inhibition in healthy subjects.

Dobesh PP, Urban JF, Shurmur SW, Oestreich JH.

Thromb J. 2015 Jan 23;13(1):3. doi: 10.1186/s12959-014-0033-x. eCollection 2015.

3.

Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety.

Dobesh PP, Oestreich JH.

Pharmacotherapy. 2014 Oct;34(10):1077-90. doi: 10.1002/phar.1477. Epub 2014 Aug 28. Review.

4.

Cangrelor for treatment during percutaneous coronary intervention.

Oestreich JH, Dobesh PP.

Future Cardiol. 2014 Mar;10(2):201-13. doi: 10.2217/fca.13.108.

PMID:
24762247
5.

Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in Native Americans.

Oestreich JH, Best LG, Dobesh PP.

Am Heart J. 2014 Mar;167(3):413-8. doi: 10.1016/j.ahj.2013.10.028. Epub 2013 Dec 19.

PMID:
24576527
6.

Effect of genetic variation in P2Y12 on TRAP-stimulated platelet response in healthy subjects.

Oestreich JH, Steinhubl SR, Ferraris SP, Loftin CD, Akers WS.

J Thromb Thrombolysis. 2014 Oct;38(3):372-9. doi: 10.1007/s11239-014-1058-5.

PMID:
24510678
7.

Pharmacodynamic interplay of the P2Y(1), P2Y(12), and TxA(2) pathways in platelets: the potential of triple antiplatelet therapy with P2Y(1) receptor antagonism.

Oestreich JH, Ferraris SP, Steinhubl SR, Akers WS.

Thromb Res. 2013 Feb;131(2):e64-70. doi: 10.1016/j.thromres.2012.11.019. Epub 2012 Dec 12.

8.

Novel direct-acting anticoagulants for risk reduction in ACS.

Dobesh PP, Oestreich JH.

J Pharm Pract. 2013 Aug;26(4):358-66. doi: 10.1177/0897190012465954. Epub 2012 Nov 19.

PMID:
23172897
9.

2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations.

Ferraris VA, Saha SP, Oestreich JH, Song HK, Rosengart T, Reece TB, Mazer CD, Bridges CR, Despotis GJ, Jointer K, Clough ER; Society of Thoracic Surgeons.

Ann Thorac Surg. 2012 Nov;94(5):1761-81. doi: 10.1016/j.athoracsur.2012.07.086. No abstract available.

PMID:
23098967
10.

Traumatic brain injury: central and peripheral role of α7 nicotinic acetylcholine receptors.

Kelso ML, Oestreich JH.

Curr Drug Targets. 2012 May;13(5):631-6. Review.

PMID:
22300031
11.

Progress of antiplatelet pharmacogenomics.

Oestreich JH.

Curr Drug Targets. 2011 Nov;12(12):1848-58. Review.

PMID:
21718233
12.

High residual platelet reactivity on standard clopidogrel maintenance dose predicts increased responsiveness to the double-standard dose in an assay-dependent manner.

Oestreich JH, Steinhubl SR, Ferraris SP, Akers WS.

Thromb Haemost. 2011 May;105(5):927-30. doi: 10.1160/TH10-09-0603. Epub 2011 Mar 24. No abstract available.

PMID:
21437349
13.
14.

Impact of genetic polymorphisms on clinical response to antithrombotics.

Lanham KJ, Oestreich JH, Dunn SP, Steinhubl SR.

Pharmgenomics Pers Med. 2010;3:87-99. Epub 2010 Jun 18.

15.

Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist.

Akers WS, Oh JJ, Oestreich JH, Ferraris S, Wethington M, Steinhubl SR.

J Clin Pharmacol. 2010 Jan;50(1):27-35. doi: 10.1177/0091270009344986. Epub 2009 Sep 24.

PMID:
19779037
16.

SCH-530348, a thrombin receptor (PAR-1) antagonist for the prevention and treatment of atherothrombosis.

Oestreich J.

Curr Opin Investig Drugs. 2009 Sep;10(9):988-96. Review.

PMID:
19705342
17.

Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose of clopidogrel.

Oestreich JH, Holt J, Dunn SP, Smyth SS, Campbell CL, Charnigo R, Akers WS, Steinhubl SR.

Coron Artery Dis. 2009 May;20(3):207-13. doi: 10.1097/MCA.0b013e328329924b.

18.

Cangrelor in percutaneous coronary intervention.

Oestreich JH, Steinhubl SR.

Expert Rev Clin Pharmacol. 2009 Mar;2(2):137-45. doi: 10.1586/17512433.2.2.137.

PMID:
24410644
19.

Platelet function analysis: at the edge of meaning.

Oestreich JH, Smyth SS, Campbell CL.

Thromb Haemost. 2009 Feb;101(2):217-9. No abstract available.

20.

Transitioning patients from cangrelor to clopidogrel: pharmacodynamic evidence of a competitive effect.

Steinhubl SR, Oh JJ, Oestreich JH, Ferraris S, Charnigo R, Akers WS.

Thromb Res. 2008;121(4):527-34. Epub 2007 Jul 13.

PMID:
17631948
21.

Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.

Spitz R, Oberthuer A, Zapatka M, Brors B, Hero B, Ernestus K, Oestreich J, Fischer M, Simon T, Berthold F.

Genes Chromosomes Cancer. 2006 Dec;45(12):1130-42.

PMID:
16958102
22.

Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.

Spitz R, Betts DR, Simon T, Boensch M, Oestreich J, Niggli FK, Ernestus K, Berthold F, Hero B.

Cancer Genet Cytogenet. 2006 May;167(1):51-6.

PMID:
16682287
23.
24.

Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q.

Boensch M, Oberthuer A, Fischer M, Skowron M, Oestreich J, Berthold F, Spitz R.

Diagn Mol Pathol. 2005 Sep;14(3):177-82.

PMID:
16106200
25.

Species-specific differences in sensorimotor adaptation are correlated with differences in social structure.

Oestreich J, Zakon HH.

J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2005 Sep;191(9):845-56. Epub 2005 Sep 13.

PMID:
16007457
26.
27.

EOD modulations of brown ghost electric fish: JARs, chirps, rises, and dips.

Zakon H, Oestreich J, Tallarovic S, Triefenbach F.

J Physiol Paris. 2002 Sep-Dec;96(5-6):451-8. Review.

PMID:
14692493
28.
29.

Plasticity of the electric organ discharge: implications for the regulation of ionic currents

Zakon H, Mcanelly L, Smith GT, Dunlap K, Lopreato G, Oestreich J, Few WP.

J Exp Biol. 1999 May;202(# (Pt 10)):1409-16.

30.

Environmentally friendly inks for medical packaging.

Oestreich J.

Regul Anal Med Waste. 1993 Aug;1(11):14-6. No abstract available.

PMID:
10132805

Supplemental Content

Loading ...
Support Center